CURE Magazine Joins US Oncology
With long-term commitments to patient education, the country's largest publication for people living with cancer joins the nation's premier oncology services company; Maintains editorial independence, yet gains strength from size and breadth of its network and resources
DALLAS, Feb. 17 /PRNewswire/ -- CURE Media Group, publisher of
the award-winning CURE magazine, is pleased to announce that it has
joined US Oncology, Inc., the nation's premier community oncology
services company working with more than 1,300 physicians and more
than 10,000 clinicians and cancer experts to advance cancer care in
America. CURE, the largest magazine in the country for people with
cancer, is the nation's trusted source for cancer patient education
and will continue its mission of providing patients and survivors
the highest quality cancer information.
"CURE's primary objective is, and always has been, to deliver
top-notch cancer information to patients, survivors, and their
caregivers at precisely the right time and place," says CURE
publisher and cancer survivor Susan McClure. "This new association
with US Oncology will help us ensure that even more patients across
the country have immediate access to the credible cancer
information they need, written in terms they can understand."
Joining the US Oncology family allows CURE to expand its reach
to the more than 720,000 cancer patients treated within the US
Oncology network, and provides the CURE team with the resources to
continue serving the individuals, hospitals, cancer centers, and
nonprofits that comprise its 325,000 other national
subscribers.
Led by McClure and fellow cancer survivor and editor-at-large
Kathy LaTour, CURE maintains its commitment to journalistic
independence and high editorial standards. Having received 30
national awards in the seven years since its launch, CURE's pledge
to providing patients with timely, up-to-date, and credible
information about treatment options, side effects, and psychosocial
issues, will remain intact and become more robust thanks to
expanded access to nationally renowned oncologists and thought
leaders within the US Oncology network.
"The US Oncology operating model ensures independence and
entrepreneurship with its affiliations, as evidenced by the
company's relationship with iKnowMed(TM), AccessMED(TM), and its
affiliated oncology practices. Our role with CURE is to provide the
magazine with the means to continue as the trusted information
source for newly diagnosed cancer patients, and to increase public
access to CURE's patient education so that every newly diagnosed
patient in the country, including those receiving care at US
Oncology affiliated practices, has easy and immediate access to the
information they need throughout their battle with cancer," says
Grant Bogle, executive vice president of US Oncology. "Similar to
other US Oncology affiliations, the CURE team will have means to
resources to expand their services into areas such as electronic
distribution and additional content development to help them
realize their vision and increase readership."
With business headquarters remaining in Dallas, CURE plans to
continue its existing business while expanding to provide the
cancer community with more resources--in print, in person, and
online.
CURE will continue to be available to patients, survivors, and
professionals free of charge. For subscription information, visit
www.curetoday.com.
About CURE Media Group
Through its unique and award-winning products, Dallas-based CURE
Media Group has become the source of information and inspiration
for those on the cancer journey. CURE Media Group's flagship
product, CURE magazine, is the indispensable guide for every stage
of the cancer experience. By combining science and humanity, CURE
helps patients, survivors, and caregivers navigate the cancer
journey and understand their diagnosis and treatment, while
providing tools to cope during and after cancer. Through the
magazine, an annual resource guide for the newly diagnosed,
educational forums, books, and an interactive website and variety
of online tools, CURE Media Group combines science and humanity to
make cancer understandable. More information can be found at
www.curetoday.com.
About US Oncology
US Oncology, Inc., headquartered in The Woodlands, Texas, works
closely with physicians, payers, biotechnology, pharmaceutical and
medical equipment manufacturers, to identify and deliver innovative
services that enhance patient access to advanced cancer care. US
Oncology supports one of the nation's foremost cancer treatment and
research networks, accelerating the availability and use of
evidence-based medicine and shared best practices.
US Oncology uses its expertise to support every aspect of the
cancer care delivery system--from drug development to distribution
and outcomes measurement--enabling the company to help increase the
efficiency and safety of cancer care. According to the company's
last quarterly earnings report, US Oncology is affiliated with
1,310 physicians operating in 493 locations, including 98 radiation
oncology facilities in 39 states. For more information, visit the
company's Web site, www.usoncology.com.
Source: CURE Media Group
CONTACT: Alexandra Hurd, Public Relations and Marketing
Specialist of
CURE Media Group, +1-214-367-3506, Cell, +1-970-443-0559,
Alexandra.Hurd@curetoday.com
Web Site: http://www.curetoday.com/
http://www.usoncology.com/
Posted: February 2010
